Four Guardians, has discovered and advanced to develop an important drug target for the HIV/AIDS pandemic for 2nd and 3rd world countries. It is a Protease Inhibitor DG 17 Prodrug. The plan it to form a US New Corp in San Diego (There is no market in Australia we have a very small infected population) – The IP is valued independently at 189 million, this would be transferred in a US New Corp. Possible you could help us to seek grants on our behalf. We are out to raise 6 to 8 M to complete clinical trials in Mexico, as MoH registration would be a stepping stone, we would then in 2.5 years have the ability to enter the larger world markets.